Newer methods may boost gene therapy s use for more diseases
MARILYNN MARCHIONE, AP Chief Medical Writer
June 2, 2021
FacebookTwitterEmail
This September 2019 photo provided by UC San Diego shows Stephanie Cherqui and patient Jordan Janz in her research lab in La Jolla, Calif. Jordan Janz knew his gamble on an experimental gene therapy for his rare disease might be paying off when he returned to work and a friend sniffed him. “He said, ‘you have a normal smell, you smell good,’” Janz recalled. “And I’m like, ‘that’s probably the nicest thing you’ve ever said.’” The 22-year-old Canadian man s previous treatment required 40 to 60 pills a day and left him smelling like rotten eggs or stinky cheese (UC San Diego via AP)AP
Newer methods may boost gene therapy s use for more diseases | iNFOnews | Thompson-Okanagan s News Source infotel.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infotel.ca Daily Mail and Mail on Sunday newspapers.
Jordan Janz knew his gamble on an experimental gene therapy for his rare disease might be paying off when he returned to work and a friend sniffed him. “He said, ‘you have a normal smell, you smell good,’” Janz recalled. “And I’m like, ‘that’s probably the nicest thing you’ve ever said.’” The 22-year-old Canadian man’s…
Share:
Pune, India, June 01, 2021 (GLOBE NEWSWIRE) The global neurological movement disorders market has been estimated to reach a value of USD 12,800 million in 2021 and is projected to grow at a CAGR of 9.80% during the forecast period from 2021 to 2030.
Neurological movement disorders are conditions that impair one s ability to generate and regulate movement. This condition predominantly affects the brain, spinal cord, as well as nerves in the body, resulting in cerebrovascular diseases, adult degenerative diseases, and other complications. The key growth drivers of the movement disorder market are the development of efficient and advanced technology, growing prevalence of neurodegenerative disorders, patent expiration of many blockbuster drugs, and the advent of new technologies globally.